Siplizumab Recruiting Phase 2 Trials for Kidney Transplantation Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT06365437A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation